Evidence map›Paper›PMID 34512864›Full record

ArticleOxidative medicine and cellular longevity2021

The Dietary Supplement

Yichao Du, Furui Zhong, Huanli Cheng, Tongxi Li, Yifan Chen, Peng Tan, Meizhou Huang, Tiancheng Liang, Yu Liu, Xianming Xia and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Involvement of role of HMGB1-NLRP3 pathway in systemic disorders.Frontiers in cell and developmental biology · 2025
    Review
  4. Emerging Roles of High-mobility Group Box-1 in Liver Disease.Journal of clinical and translational hepatology · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yichao DuAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.ORCID https://orcid.org/0000-0002-2222-4908
Furui ZhongDepartment of General Surgery, Zigong Fourth People's Hospital, Zigong 643000, China.
Huanli ChengDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Tongxi LiDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Yifan ChenDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Peng TanAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Meizhou HuangAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Tiancheng LiangLuzhou Municipal Hospital of Traditional Chinese Medicine, Luzhou 646000, China.
Yu LiuXichang People's Hospital, Xichang 615000, China.
Xianming XiaAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.ORCID https://orcid.org/0000-0002-0374-529X
Wenguang FuAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.ORCID https://orcid.org/0000-0003-3672-9728
Affiliated Hospital of Southwest Medical University · CNXichang University · CNZigong First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to investigate the protective effect of

Indexed as

AnimalsDietary SupplementsDisease Models, AnimalEndoplasmic Reticulum StressHMGB1 ProteinHumansHypolipidemic AgentsInflammasomesLiverMaleMiceNLR Family, Pyrin Domain-Containing 3 ProteinPhenylpropionatesReperfusion Injurygamma-oryzanolHMGB1 ProteinHypolipidemic AgentsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinPhenylpropionates

Identifiers

PMID34512864
PMCPMC8433023
OpenAlexW3196577558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.